Confident, Data-Driven Decisions with Journal Citation Reports

A Smarter Way to Publish and Curate in 2025
Register Now

Join this free webinar on Jul 22 on 11:00AM IST

Clarivate has released the 2025 update to the Journal Citation Reports (JCR) with this year's focus on A Smarter Way to Publish and Curate.

In a scholarly publishing landscape shaped by rising retractions, predatory journals, and misuse of metrics, how can researchers and librarians make confident, data-driven decisions?

Join this insightful webinar to explore how Journal Citation Reports (JCR) empowers you to evaluate journals with transparency, trust, and multidimensional intelligence. Whether you're submitting your first manuscript or managing institutional collections, JCR helps you navigate complexity with clarity.

What will the webinar cover?
  • Key trends in scholarly publishing and the growing need for research integrity
  • How to use JCR’s journal profiles to align with your research goals and audience
  • The role of JIF, JCI, and visualizations in responsible research assessment
  • Tools to support library curation and open access strategy
  • What’s new in JCR 2025: Retraction-aware JIF, unified rankings, and API integrations

Stay ahead of the curve with the latest tools and insights that support ethical publishing, smarter submissions, and evidence-based collection development.

Don’t miss this opportunity to sharpen your publishing strategy and collection planning!

Register below and we'll send the details.

HIDDEN FIELDS BELOW

Speaker's Bio

Dr. Subhasree Nag,
Strategic Customer Success Consultant,
Clarivate

Dr.  Subhasree  Nag  is  a  senior  business  solution  consultant  for  the scholarly research and life sciences division at Clarivate.  

She  completed  her  PhD  from  Texas  Tech  University  Health  Sciences Center,  USA  and  her  post-doctoral  training  from  Pacific  Northwest National Laboratory, USA.

A pharmacologist and toxicologist by training, she has more than 8 years of  research  experience  in  anticancer  drug  discovery  and pharmacokinetics  areas  with  25  peer  reviewed  publications  and  more than 1500 citations.

At Clarivate, she is involved in promoting Clarivate's scholarly research, drug discovery and intellectual property (IP) solutions, conducting author and research capacity workshops, bespoke consulting projects, etc.

She  was  a  co-author  on  the  UGC-Good  Academic  Research  Practices guidance  document released  in  2020.  She  also  writes for  the  Clarivate pharma  industry  magazine,  Bioworld,  where  she  contributes  to  articles related to early-stage discovery and preclinical studies.